For as long as medicine has fought infection, bacterial biofilms have quietly held the upper hand — dense, self-protective matrices that chemical agents cannot easily breach. Researchers at the University of Illinois Urbana-Champaign have now turned the problem inside out, engineering microparticles that infiltrate these bacterial fortresses and detonate oxygen bubbles from within, collapsing the very structure that made the infection untreatable. The approach reframes chronic wounds and contaminated surgical instruments not merely as chemical challenges but as mechanical ones — and in doing s
Oxygen-Bubble Microparticles Outperform Traditional Methods in Biofilm Removal
Chronic wounds affect millions of patients globally, with biofilms present in 60-80% of cases, contributing to treatment resistance and delayed healing.
The particles infiltrate the biofilm first, then generate bubbles inside the matrix, disrupting it.
Mark
Why does a biofilm make infection so hard to treat? It sounds like just a layer of bacteria.
Mimi
It's not just a layer—it's a fortress. The bacteria secrete proteins and other compounds that form a dense matrix around them. Chemicals can't penetrate it easily. The bacteria inside are essentially shielded from antibiotics and disinfectants.
Mark
So the new approach is mechanical rather than chemical?
Mimi
Exactly. Instead of trying to dissolve the biofilm with chemicals, these particles physically infiltrate it and generate tiny oxygen bubbles that rupture and disrupt the structure from inside. It's like using pressure to break something apart rather than trying to dissolve it.
Mark
How does that help with surgical instruments? Those are already cleaned with steam and detergent.
Mimi
The problem is that biofilms hide in tiny crevasses and serrations where the detergent can't reach. The particles are small enough to get into those confined spaces, and the bubbles they generate can dislodge the biofilm where traditional methods fail.
Mark
And for wounds, you're embedding the particles in a bandage?
Mimi
Yes. The bandage has the particles beneath a mesh that releases hydrogen peroxide, which activates the bubble generation right at the wound surface. It's continuous, localized treatment—the wound gets repeatedly blasted with these tiny scrubbing bubbles.
Mark
The study mentions antibiotics working at one-tenth the normal dose. That's significant.
Mimi
It is. Once the biofilm is disrupted, antibiotics can actually penetrate and reach the bacteria. You don't need as much drug to be effective, which means less systemic exposure and fewer side effects.
Mark
What's the next step?
Mimi
Large-animal trials of the bandages, and testing on endoscopes, which are notoriously difficult to clean. They're also working on scaling up manufacturing. The researchers believe this could apply to any biofilm problem, clinical or industrial.
O Pulso
- Biofilms shelter bacteria inside a dense protein matrix that hydrogen peroxide and antibiotics cannot reliably penetrate, leaving chronic wounds infected and surgical instruments dangerously contaminated despite standard cleaning protocols.
- Tiny biosilica cylinders coated in manganese dioxide now infiltrate that matrix and, activated by hydrogen peroxide, generate oxygen bubbles that rupture from the inside — mechanically dismantling the biofilm rather than merely attacking its surface.
- On surgical forceps, the microparticles combined with autoclaving achieved a five-fold reduction in remaining biofilm, outperforming enzymatic detergents in the tight serrations where contamination most stubbornly persists.
- Embedded in a wound dressing that steadily releases hydrogen peroxide, the particles cleared antibiotic-resistant biofilms in infected mouse wounds, accelerated healing, and allowed antibiotics to work at doses ten times lower than standard treatment.
- With a patent secured and manufacturing partnerships underway, the team is moving toward large-animal trials and endoscope sterilization tests — aiming to bring the technology to the 10.5 million Medicare patients whose chronic wounds are complicated by biofilm.
For as long as medicine has fought infection, bacterial biofilms have quietly held the upper hand — dense, self-protective matrices that chemical agents cannot easily breach. Researchers at the University of Illinois Urbana-Champaign have now turned the problem inside out, engineering microparticles that infiltrate these bacterial fortresses and detonate oxygen bubbles from within, collapsing the very structure that made the infection untreatable. The approach reframes chronic wounds and contaminated surgical instruments not merely as chemical challenges but as mechanical ones — and in doing so, opens a path toward healing millions of patients for whom standard treatment has long fallen short.
A research team at the University of Illinois Urbana-Champaign has engineered a new class of microparticles designed to solve one of medicine's most stubborn mechanical problems: bacterial biofilms. These dense matrices of cells and proteins shield infections from chemical attack, making chronic wounds and contaminated surgical instruments resistant to standard treatment. The team's solution is not to dissolve the biofilm from outside, but to infiltrate it first — tiny cylindrical particles of biosilica coated in manganese dioxide penetrate the matrix and, when exposed to hydrogen peroxide, generate oxygen bubbles that rupture from within, propelling the particles deeper and collapsing the structure around them.
The first application, published in ACS Applied Materials and Interfaces, targeted surgical instruments. Standard cleaning with enzymatic detergents and autoclaving leaves biofilm clinging in the fine serrations of tools like forceps. The microparticles, combined with autoclaving, achieved a five-fold reduction in remaining biofilm — succeeding precisely where conventional methods could not reach.
The second application, detailed in Advanced Science, embedded the particles into wound dressings. A mesh layer steadily releases hydrogen peroxide, activating bubble generation directly at the wound site. In mouse models with antibiotic-resistant biofilms, the dressing reduced infection, accelerated skin regrowth, and — most strikingly — allowed antibiotics to work effectively at doses ten times lower than standard treatment. The central insight, as the researchers describe it, is that treatment-resistant wounds are fundamentally a biofilm problem: remove the mechanical barrier, and the drugs already available can do their work.
The team now plans to test the particles on surgical endoscopes, whose hollow tubes present even greater cleaning challenges, and to advance toward large-animal trials before any human application. A patent is secured and manufacturing partnerships are forming. The technology requires no harsh chemicals and no specialized equipment, raising the possibility of broad clinical and industrial use — with particular urgency for the millions of patients whose chronic wounds have long resisted every treatment tried.
A team at the University of Illinois Urbana-Champaign has engineered a solution to a problem that has frustrated surgeons and wound care specialists for centuries: biofilms, those dense, protective matrices of bacterial cells and proteins that shield infections from chemical attack. The researchers developed tiny cylindrical particles made of biosilica and coated with manganese dioxide that, when exposed to hydrogen peroxide, generate microscopic oxygen bubbles inside the biofilm itself—mechanically disrupting the infection from within rather than merely scrubbing its surface.
The conventional approach to biofilm removal has always been limited. Hydrogen peroxide, used for generations, can kill bacteria on contact, but it cannot penetrate the dense matrix that protects them. Surgical instruments are cleaned with enzymatic detergents and autoclaving—high-temperature steam under pressure—yet biofilms stubbornly persist in the tiny crevasses and serrations of the tools. Chronic wounds, which affect roughly 10.5 million Medicare beneficiaries in the United States alone, harbor biofilms in 60 to 80 percent of cases, making them resistant to standard antibiotic treatment. The problem is mechanical as much as chemical: the biofilm is a barrier, and no amount of chemical agent can easily breach it.
Hyunjoon Kong, a chemical and biomolecular engineering professor leading the research, describes the innovation as a shift in strategy. Rather than trying to dissolve the biofilm with chemicals, the team's particles infiltrate it first, then generate bubbles that accumulate and rupture inside the matrix, propelling the particles deeper and continuing the disruption. Graduate student Joo Hun Lee, first author of one of the papers, worked with collaborators including bioengineering professor Stephen Boppart to observe this process using high-speed cameras and optical coherence tomography—essentially watching the bubbles form, rupture, and the biofilm collapse in real time.
The first paper, published in ACS Applied Materials and Interfaces, demonstrated the particles' effectiveness on surgical instruments. When the researchers compared biofilm remaining in the serrations of forceps after standard cleaning protocols with biofilm remaining after treatment with the microparticles, they found comparable or superior results. More striking: the microparticles achieved a five-fold reduction in remaining biofilm when combined with autoclaving. In confined spaces where enzymatic detergents cannot easily reach, the particles succeeded where traditional methods failed—a difference Kong describes as huge.
The second application, detailed in Advanced Science, embedded the microparticles into bandages designed to treat infected wounds. The researchers placed the particles beneath a mesh that steadily releases hydrogen peroxide, activating the bubble generation at the wound site. They called it a microblasting wound dressing. In mouse models with antibiotic-resistant biofilms similar to those seen in human patients, the dressing dramatically reduced the biofilm burden and accelerated healing, with less inflammation and faster skin and hair regrowth. Perhaps most significantly, the disrupted biofilm allowed antibiotics to penetrate and work effectively at doses ten times lower than standard treatment—a finding with profound implications for reducing antibiotic exposure while maintaining efficacy.
Postdoctoral researcher Yujin Ahn, first author of the wound-healing paper, emphasizes that the central insight is reframing treatment-resistant wounds as fundamentally a biofilm problem. The dense matrix limits drug penetration and shields bacteria from therapy. By mechanically removing that barrier, the team has shown that antibiotics can work harder and faster, and inflammation can be reduced during the healing process.
The work is not yet complete. The researchers plan to test the microparticles on surgical endoscopes, whose hollow inner tubes present cleaning challenges even more severe than those of forceps. They also intend to move toward large-animal trials of the bandages before any human application. A patent has been secured, and the team is working with manufacturing partners to scale production. Kong sees applications far beyond wounds and surgical instruments—anywhere biofilms form and resist conventional treatment. The technology requires no harsh chemicals and no specialized equipment, making it potentially accessible across clinical and industrial settings. The research was supported by the National Science Foundation, the National Institutes of Health, the Chan Zuckerberg Biohub Chicago, and the Korean Ministry of Trade, Industry and Energy.
Citações Notáveis
Biofilms are a dense matrix of bacterial cells and proteins. While sterilizing agents can kill bacteria, the matrix protects them, making it much harder to treat or clean with chemicals.— Hyunjoon Kong, University of Illinois chemical and biomolecular engineering professor
Treatment-resistant wounds can be understood as a biofilm problem. Dense polymicrobial biofilm matrices limit drug penetration and shield bacteria from therapy.— Hyunjoon Kong
Quer a matéria completa?
Leia o original em News-Medical ↗
Education